Abstract
Selinexor in Combination with R-GDP for Patients with Relapsed/Refractory B-Cell Lymphoma: Results of the Selinda Phase Ib Lysa Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood-2021-145150
Copy DOIJournal: Blood | Publication Date: Nov 5, 2021 |
Citations: 2 |
Selinexor in Combination with R-GDP for Patients with Relapsed/Refractory B-Cell Lymphoma: Results of the Selinda Phase Ib Lysa Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have